Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Drugs

Senior couple smiling and enjoying each other's company indoors.

Korsana’s Alzheimer’s Treatment Promises Safer Care — But When?

February 20, 2026 No Comments

A safer Alzheimer’s treatment may be on the horizon — but families still have meaningful choices today.

Doctor shows patient brain scans on tablet

How Doctors Decide Who Qualifies for Leqembi

February 19, 2026 No Comments

Many diagnosed patients won’t qualify — here are the
7 medical criteria.

ai generated, neuron, brain, synapses, biology, science, thinking, cell, anatomy, nerves, neural, mind, dendrites, connection, physiology, neurology

How Lecanemab Clears Amyloid and Slows Alzheimer’s—even as Tau Spreads

February 5, 2026 1 Comment

New early-onset Alzheimer’s data show that lecanemab can slow functional decline—even while tau continues to spread in the brain. The research helps explain how amyloid-lowering treatments may still preserve daily life, despite the disease’s complexity.

What 400 Alzheimer’s Patients Gained From Leqembi and Kisunla

January 29, 2026 No Comments

In a one-hour seminar, a leading neurologist answers the most important questions families ask about what these new therapies can realistically deliver — from effectiveness and safety to eligibility, infusion logistics, cost, and access.

Happy senior couple walking outdoors, holding colorful flowers. A delightful moment capturing love and togetherness.

Leqembi Likes Asia’s Genes. Why?

December 30, 2025 No Comments

New evidence suggests genetics—not geography—may explain why Leqembi causes fewer ARIA brain side effects in parts of Asia, and what that means for families everywhere.

"Alzheimer's Treatment Demand" chart behind patient, caregiver and doctor.

Leqembi Prescriptions Could Rise Sharply. Why?

December 21, 2025 No Comments

Alzheimer’s treatment eligibility may be far larger than previously thought. A major Nature study using blood tests suggests millions more older adults could qualify for treatment than current use reflects. As diagnosis becomes easier, demand for drugs like Leqembi could shift sharply.

Exelon (Rivastigmine Transdermal Patch for Alzheimer's)

Rivastigmine Alzheimer’s Patch: New Research, Better Comfort

December 11, 2025 No Comments

New studies highlight smoother tolerability, easier routines, and practical safety updates that make the rivastigmine patch an increasingly caregiver-friendly option.

One Weight-Loss Drug Slowed Alzheimer’s, Two Didn’t. That’s Good News.

December 9, 2025 No Comments

Three major GLP-1 trials came out in late 2025. One weight-loss drug slowed early Alzheimer’s decline, while two others failed. Surprisingly, this mixed pattern may point the way toward a promising new treatment direction.

Happy senior couple sharing a smile in a cozy outdoor setting, capturing a moment of love and connection.

Lecanemab Can Delay Alzheimer’s 8 Years: New Data, New Hope

December 7, 2025 No Comments

New long-term data suggests lecanemab could delay the shift from mild memory loss to moderate Alzheimer’s by up to eight years—offering families precious time and renewed hope.

cyber brain, computer, brain, information, the internet, technology, digital, jobs, remote, web3, network, electric circuit, artificial intelligence, brain, brain, brain, web3, artificial intelligence, artificial intelligence, artificial intelligence, artificial intelligence, artificial intelligence

Leqembi: Slowing Alzheimer’s — What You Need to Know

November 16, 2025 2 Comments

Leqembi is one of the first Alzheimer’s treatments proven to slow decline. A new MRI study helps explain what it can—and cannot—do in the brain’s early months, offering clearer expectations for caregivers.

A Morning Music Lift Lasts All Day in Alzheimer’s

February 26, 2026

Learn about ‘personalized music for dementia’ and its powerful effect on Alzheimer’s. See the Director of the hit film, ‘Alive Inside’, on the dementia-impact of music.

Citalopram Fights Agitation in Alzheimer’s

February 26, 2026

The antidepressant drug citalopram, also sold under the brand names Celexa and Cipramil, significantly relieves agitation in Alzheimer’s. Learn about the benefits and side-effects.

Art Gives Fun and Meaning To Alzheimer’s Patients

February 25, 2026

The brush strokes are precise, the colors vibrant. See a Colorado art program help patients rise above dementia, while the paintings raise money for The Alzheimer’s Association.

Most Popular Stories

A Morning Music Lift Lasts All Day in Alzheimer’s

Learn about ‘personalized music for dementia’ and its powerful effect on Alzheimer’s. See the Director of the hit film, ‘Alive Inside’, on the dementia-impact of music.

Art Gives Fun and Meaning To Alzheimer’s Patients

The brush strokes are precise, the colors vibrant. See a Colorado art program help patients rise above dementia, while the paintings raise money for The Alzheimer’s Association.

How Physical Activity Turns Back the Brain’s Clock

The protein BDNF builds synapses in the human brain, nurturing brain cells and fighting off dementia. While there is no artificial way of boosting it, social and cognitive activity can.

Poor Memory + Slow Walking = Dementia?

People may not have easy access to sophisticated, expensive dementia tests. A simple test from Einstein Medicine uses a stopwatch and a few questions to determine one’s risk of dementia. The potential payoff could be tremendous for individuals, their families and society.